Great West Life Assurance CO Krystal Biotech, Inc. Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

A detailed history of Great West Life Assurance CO transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 26,776 shares of KRYS stock, worth $5.21 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

26,776

Previous 27,373 2.18%

Holding current value

$5.21 Million

Previous $5.03 Million 3.2%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$174.7 - $213.66 $104,295 - $127,555	-597 Reduced 2.18%	26,776 $4.87 Million
Q2 2024 Aug 12, 2024	BUY	$153.12 - $183.64 $3.71 Million - $4.45 Million	24,245 Added 775.1%	27,373 $5.03 Million
Q1 2024 May 13, 2024	BUY	$108.01 - $179.35 $150,889 - $250,551	1,397 Added 80.7%	3,128 $557,000
Q3 2023 Nov 14, 2023	BUY	$108.51 - $130.22 $112,850 - $135,428	1,040 Added 150.51%	1,731 $201,000
Q2 2023 Aug 10, 2023	SELL	$78.48 - $130.32 $4,316 - $7,167	-55 Reduced 7.37%	691 $82,000
Q1 2023 May 12, 2023	SELL	$72.39 - $84.27 $19,328 - $22,500	-267 Reduced 26.36%	746 $60,000
Q2 2022 Aug 12, 2022	BUY	$48.93 - $73.47 $49,566 - $74,425	1,013 New	1,013 $67,000
Q2 2022 Aug 09, 2022	SELL	$48.93 - $73.47 $49,566 - $74,425	-1,013 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$51.99 - $72.11 $17,988 - $24,950	346 Added 51.87%	1,013 $72,000
Q2 2021 Aug 11, 2021	SELL	$62.14 - $81.82 $21,003 - $27,655	-338 Reduced 33.63%	667 $45,000
Q1 2021 May 17, 2021	BUY	$59.42 - $85.46 $23,470 - $33,756	395 Added 64.75%	1,005 $77,000
Q3 2019 Oct 25, 2019	SELL	$34.72 - $51.3 $42,011 - $62,073	-1,210 Reduced 66.48%	610 $21,000
Q2 2019 Jul 31, 2019	BUY	$27.2 - $41.2 $49,504 - $74,984	1,820 New	1,820 $0

Others Institutions Holding KRYS

# of Institutions

311

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.99B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Krystal Biotech, Inc. Transaction History